Skip to content

poloko

Broadcast The Lastest News

  • News
  • Business
  • Technology
  • Lifestyle
  • Sport
  • Privacy Policy
  • T & C

Category: Lifestyle

  • Home
  • Lifestyle

Category: Lifestyle

Lifestyle

A new therapeutic target against the most common lung cancer

By polokonet September 25, 2022September 19, 2022

TIMP-1 protein levels in both tissues and blood have been repeatedly associated with a poor prognosis in lung cancers, but its role has been unknown. Now, a study led by…

Read More
Lifestyle

Polycystic ovary syndrome is going undetected in Nigeria

By polokonet September 24, 2022September 19, 2022

Polycystic ovary syndrome is the most common gynecological endocrine disorder in women of reproductive age. It affects between 4% and 20% of women globally and is influenced by genetic and…

Read More
Lifestyle

Weight loss: The time of day you eat your biggest meal has little effect says new study

By polokonet September 23, 2022September 19, 2022

Some of the most popular diet advice in recent years has centered around the idea that the right timing for your meals can make a big difference in the amount…

Read More
Lifestyle

Blood marker which predicts the risk of osteoporotic hip fractures in older men

By polokonet September 22, 2022September 19, 2022

NUS scientists have discovered that blood levels of the chemokine protein CXCL9 reliably predict the risk of osteoporotic hip fractures in Chinese men. Healthy bone requires a balanced activity of…

Read More
Lifestyle

Anti-diarrhea medication may help treat core autism symptoms

By polokonet September 21, 2022September 19, 2022

There are currently no effective treatments for the core symptoms of autism spectrum disorder (ASD), such as difficulties with socializing and communicating. A new study uses a computer-based protein interaction…

Read More
Lifestyle

Immunotherapy before surgery induces complete response in more than half of patients with common skin cancer

By polokonet September 20, 2022September 19, 2022

In an international, multicenter Phase II clinical trial led by The University of Texas MD Anderson Cancer Center, 63.3% of patients with stage II–IV cutaneous squamous cell carcinoma (CSCC) saw…

Read More
Lifestyle

Patients with refractory metastatic colorectal cancer experience survival benefits with fruquintinib

By polokonet September 19, 2022September 19, 2022

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in patients…

Read More

Recent Posts

  • Chelsea hold positive talks with Graham Potter after sacking Thomas Tuchel
  • A new therapeutic target against the most common lung cancer
  • Sea Ltd shuts operations in some Latin American countries, cuts Free Fire staff in Shanghai
  • Twitter agreed to $7 million settlement for whistleblower before he went public with allegations
  • Electrician becomes landlord of tiny British island and is coronated with a beer shower

Categories

  • Business
  • Lifestyle
  • News
  • Sport
  • Technology
Theme of 96 THEME.